These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

789 related items for PubMed ID: 9348181

  • 1. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo.
    Nishihara E, Nagayama Y, Mawatari F, Tanaka K, Namba H, Niwa M, Yamashita S.
    Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181
    [Abstract] [Full Text] [Related]

  • 2. DNA-liposome complexes transduction of herpes simplex virus thymidine kinase renders human tongue cancer cell line sensitive to ganciclovir in vitro.
    Wang JH, Situ ZQ, Wu JZ, Liu B.
    Chin J Dent Res; 2000 Dec; 3(4):44-8. PubMed ID: 11314087
    [Abstract] [Full Text] [Related]

  • 3. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
    Tang Q, Zhang D, Wan M, Jin L.
    Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
    [Abstract] [Full Text] [Related]

  • 4. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
    Zhao Y, Zhang X, Hui H.
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):113-5. PubMed ID: 10488424
    [Abstract] [Full Text] [Related]

  • 5. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.
    Wildner O, Blaese RM, Morris JC.
    Hum Gene Ther; 1999 Nov 01; 10(16):2679-87. PubMed ID: 10566896
    [Abstract] [Full Text] [Related]

  • 6. Retrovirus-mediated suicide gene/prodrug therapy targeting thyroid carcinoma using a thyroid-specific promoter.
    Braiden V, Nagayama Y, Iitaka M, Namba H, Niwa M, Yamashita S.
    Endocrinology; 1998 Sep 01; 139(9):3996-9. PubMed ID: 9724055
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L, Hwang R, Chiang Y, Gordon EM, Anderson WF, Parekh D.
    Clin Cancer Res; 1998 Mar 01; 4(3):731-41. PubMed ID: 9533543
    [Abstract] [Full Text] [Related]

  • 8. Limitations of retrovirus-mediated HSV-tk gene transfer to pulmonary adenocarcinoma cells in vitro and in vivo.
    Zhang L, Wikenheiser KA, Whitsett JA.
    Hum Gene Ther; 1997 Mar 20; 8(5):563-74. PubMed ID: 9095408
    [Abstract] [Full Text] [Related]

  • 9. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.
    J Gene Med; 2004 Mar 20; 6(3):288-99. PubMed ID: 15026990
    [Abstract] [Full Text] [Related]

  • 10. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ, Gore M, Smiley WR, Kanemitsu MY, Jolly DJ, Read SB, Nicholas T, Kruse CA.
    Cancer Gene Ther; 2002 Jan 20; 9(1):87-95. PubMed ID: 11916247
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer.
    Mäkinen K, Loimas S, Wahlfors J, Alhava E, Jänne J.
    J Gene Med; 2000 Jan 20; 2(5):361-7. PubMed ID: 11045430
    [Abstract] [Full Text] [Related]

  • 12. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
    Xing Y, Lu G, Xiao Y, Zeng F, Zhang Q, Xiong P, Feng W.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 10; 82(21):1484-7. PubMed ID: 12509912
    [Abstract] [Full Text] [Related]

  • 13. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
    LeMay DR, Kittaka M, Gordon EM, Gray B, Stins MF, McComb JG, Jovanovic S, Tabrizi P, Weiss MH, Bartus R, Anderson WF, Zlokovic BV.
    Hum Gene Ther; 1998 May 01; 9(7):989-95. PubMed ID: 9607410
    [Abstract] [Full Text] [Related]

  • 14. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
    Hayashi K, Lee JB, Maitani Y, Toyooka N, Nemoto H, Hayashi T.
    J Gene Med; 2006 Aug 01; 8(8):1056-67. PubMed ID: 16779868
    [Abstract] [Full Text] [Related]

  • 15. Retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for hepatocellular carcinoma.
    Gao Ding Cheng, An W, Dai J.
    Cell Res; 1999 Sep 01; 9(3):225-35. PubMed ID: 10520605
    [Abstract] [Full Text] [Related]

  • 16. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S, Krisky DM, Marconi PC, Tamura M, Shimizu K, Yoshimine T, Cohen JB, Glorioso JC.
    Gene Ther; 2000 Sep 01; 7(17):1483-90. PubMed ID: 11001368
    [Abstract] [Full Text] [Related]

  • 17. Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma.
    Kuriyama S, Mitoro A, Yamazaki M, Tsujinoue H, Nakatani T, Akahane T, Toyokawa Y, Kojima H, Okamoto S, Fukui H.
    Scand J Gastroenterol; 1999 Oct 01; 34(10):1033-41. PubMed ID: 10563675
    [Abstract] [Full Text] [Related]

  • 18. Gene therapy of established medullary thyroid carcinoma with herpes simplex viral thymidine kinase in a rat tumor model: relationship of bystander effect and antitumor efficacy.
    Zhang R, DeGroot LJ.
    Thyroid; 2000 Apr 01; 10(4):313-9. PubMed ID: 10807059
    [Abstract] [Full Text] [Related]

  • 19. Transcriptionally targeted retroviral vector for combined suicide and immunomodulating gene therapy of thyroid cancer.
    Barzon L, Bonaguro R, Castagliuolo I, Chilosi M, Gnatta E, Parolin C, Boscaro M, Palù G.
    J Clin Endocrinol Metab; 2002 Nov 01; 87(11):5304-11. PubMed ID: 12414907
    [Abstract] [Full Text] [Related]

  • 20. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line.
    Trinh QT, Austin EA, Murray DM, Knick VC, Huber BE.
    Cancer Res; 1995 Nov 01; 55(21):4808-12. PubMed ID: 7585511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.